全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

-

ISSN Print: 2397-768X

ISSN Online:

主页: https://www.nature.com/npjprecisiononcology

分享:




Go

Cancer prevention and screening: the next step in the era of precision medicine

Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition

Immunotherapeutic advances in gastrointestinal malignancies

CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology

Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity

Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types

A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer

The PGC-1/ERR network and its role in precision oncology

Precision oncology of lung cancer: genetic and genomic differences in Chinese population

RNAMethyPro: a biologically conserved signature of N6-methyladenosine regulators for predicting survival at pan-cancer level

Artificial intelligence for precision oncology: beyond patient stratification

Accumulation of genetic and epigenetic alterations in normal cells and cancer risk

Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer data

Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology

Organotropism: new insights into molecular mechanisms of breast cancer metastasis

Role of nonresolving inflammation in hepatocellular carcinoma development and progression

Adaptive metabolic pattern biomarker for disease monitoring and staging of lung cancer with liquid biopsy

Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution

Cardiotoxicity with vascular endothelial growth factor inhibitor therapy

Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma

Tumor evolution and chemoresistance in ovarian cancer

Liquid biopsy for pediatric central nervous system tumors

Universal cancer screening: revolutionary, rational, and realizable

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis

Immunogenetics of glioblastoma: the future of personalized patient management

Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers

Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response

Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations

SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response

A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway

Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour

Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology

Emerging role of precision medicine in biliary tract cancers

Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy

Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways

Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2

The Hormel Institute International Cancer Research Conference—2017 meeting report

Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathway

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705